I would say the entire cross-functional development team, including engineers. Engineers know how the design should work, manufacturing knows how it actually gets built, service knows how it fails in the field, and quality knows the history of past defects….   Read more»

User training is a type of risk mitigation because it helps reduce mistakes and prevent harm when using medical devices. However, training is considered one of the weakest ways to control risk because people can forget instructions, misunderstand procedures, or…   Read more»

Engineers should start making the device when they have checked all the possible dangers, fixed or planned for each one, and tested the final version to show it works safely and lasts. They should also make sure the device follows…   Read more»

Subjective user needs are transformed into measurable requirements during the design input process, where qualitative expectations are translated into specific, testable criteria. These requirements are documented in the Design Input Documents and Design Specifications to ensure they are clear, unambiguous,…   Read more»

I agree with your point @ha572 that preclinical results, especially from animal testing, can’t fully predict how a device will perform in people. That’s exactly why clinical trials are necessary, and also why they have to be designed carefully to…   Read more»

@jacobthomas64  Nice summary! I agree that clinical research needs many groups working together, and that GCP and ethics boards are key to protecting patients. On your questions, I think money and ethics can coexist if independent groups oversee the study…   Read more»

I agree that virtual clinical trials may substitute for some human studies, particularly in early dose-finding, trial design, and the use of synthetic control arms, but I do not believe they can fully replace traditional trials. The human organism varies…   Read more»

@dev-doshi, I agree with your point that financial models are important, but they should not be the only factor when deciding whether to invest in medical technology. I believe companies should consider both short-term costs and the long-term benefits a…   Read more»

I agree that outsourcing can help companies reduce costs and focus on their main areas of expertise. However, I believe that in the medical device industry, cost should not be the only factor when making these decisions. Quality control, patient…   Read more»

@aysegultinas, I agree with your point that there should be a balance between protecting innovation and holding medical device companies accountable. I believe leaders in the medical device industry should have a higher level of responsibility because their decisions directly…   Read more»

From my experience working in a medical laboratory, I can see why the Cost of Quality is so important. In the lab, we perform quality control, instrument maintenance, calibrations, and specimen checks before releasing patient results. These processes require time,…   Read more»

Yes, it can. Too much quality can slow innovation, but in medical devices it is necessary. Quality control is a required part of compliance. A medical device exists to deliver or support patient care. Quality control acts as an evaluator…   Read more»

The QA professional should make the final decision. AI is a useful tool that speeds up analysis, but it is not fully reliable. AI in this scenario can lack data and context needed to reach a conclusion, and it can…   Read more»

@Ahmed-elmonier, good point about claims changing the pathway. It connects to what we talked about with the 510(k) process. To get cleared, a new device has to be shown to be similar to a device already on the market, and…   Read more»

The 2011 article “Medical Devices and the Public’s Health – The FDA 510(K) Clearance Process at 35 Years” raises two major concerns. First, there is doubt about whether the 510(k) process actually ensures that medical devices on the market are…   Read more»

To show compliance, companies keep a signed consulting agreement, a record of the business need, proof of the work done, and payment records. Fair market value means paying a fair rate for the real service, not for how much the…   Read more»

M.O.R.E. is a perspective PMI introduced in 2025 as a call to action for project professionals to take accountability beyond meeting success metrics and to deliver value to stakeholders (PMI, 2025). It is not a conflict-resolution method, but its principles…   Read more»

According to the PMBOK Guide, initiation is the process of formally recognizing that a new project exists or that an existing project should continue into its next phase. In practice, it answers the foundational questions of why the project is…   Read more»